LTRN
USDLantern Pharma Inc. Common Stock
Prix en Temps Réel
Graphique des Prix
Métriques Clés
Métriques de Marché
Ouverture
$3.260
Haut
$3.510
Bas
$3.020
Volume
0.09M
Fondamentaux de l'Entreprise
Capitalisation Boursière
36.9M
Industrie
Biotechnologie
Pays
United States
Statistiques de Trading
Volume Moyen
0.13M
Bourse
NCM
Devise
USD
Intervalle sur 52 Semaines
Actualités Connexes
Lantern Pharma to Present AI-Driven Cancer Drug Development & Research Platforms at Inaugural AI for Biology and Medicine Symposium at UNT
Lantern showcases two commercially ready, machine learning platforms that have the potential to accelerate drug discovery from months to days and dramatically reduce costs. predictBBB.ai and LBx-AI, will both be
Lantern Pharma Presents LP-284 Clinical Data at 25th LL&M Congress, Highlighting Complete Response in Therapeutically Exhausted DLBCL Patient & Therapeutic Potential in Advanced B-Cell Cancers.
AI-advanced drug candidate achieves complete metabolic response after two cycles in patient who failed CAR-T and bispecific antibody therapies, validating LP-284's mechanism of action. A novel differentiated
Lantern Pharma to Present at the ThinkEquity Conference in NYC on October 30, 2025
Lantern Pharma Inc. (NASDAQ:LTRN), an artificial intelligence (AI) company dedicated to developing cancer therapies and transforming the cost, pace, and timeline of oncology drug discovery and development, today
Actions Connexes
Restez Informé
Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.